| 7:00am | Check-in & Breakfast Available in Exhibit Hall |
| 7:55am | Horizon CME App Overview and CE Housekeeping |
| 8:00am | Welcome and Introductions |
| 8:05am | (01) Myelodysplastic Syndromes » Andrew Brunner, MD – Oncologist | Massachusetts General Hospital | Boston, MA |
| 8:35am | (02) Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia » Michelle Hyunju Lee, MD – Hematologist | Massachusetts General Hospital | Boston, MA |
| 9:05am | (03) ITP/TTP, Immune Hemolysis, and aHUS » Rushad Patell, MD – Hematologist | Beth Israel Deaconess Hospital | Boston, MA |
| 9:35am | (04) Stump the Faculty Q+A » Faculty for Sessions (01) – (03) |
| 9:50am | Information About the Cancer Charities & Trivia For Charity Break |
| 9:55am | Break – Trivia for Charity in Exhibit Hall |
| 10:20am | (05) Venous Thromboembolism/Anticoagulation » Jean M. Connors, MD – Medical Director, Anticoagulation Management Service | Brigham and Women’s Hospital, Dana-Farber Cancer Institute | Boston, MA |
| 10:50am | (06) Sickle Cell Disease: Hemoglobinopathies » Martin H. Steinberg, MD – Professor, Hematology & Medical Oncology | Professor, Pathology & Laboratory Medicine | Boston University | Boston, MA |
| 11:20am | (07) Transfusion Medicine and Apheresis » Walter “Sunny” Dzik, MD – Associate Pathologist, Massachusetts General Hospital | Associate Professor of Pathology, Harvard Medical School | Boston, MA |
| 11:50am | (08) Stump the Faculty Q+A » Faculty for Sessions (05) – (07) |
| 12:05pm | Gather Lunch |
| 12:10pm | Buffet Lunch Non-CME/CE Presentation Sponsored by Novartis: Discover SCEMBLIX Understanding How SCEMBLIX May Fit Into the Treatment Landscape for Adults With Ph+ CML-CP » Dr. Baratam, MBBS |
| 12:55pm | Dessert Break in Exhibit Hall |
| 1:00pm | (09) Acute Lymphoblastic Leukemia » Marlise R. Luskin, MD, MSCE – Associate Professor of Medicine, Harvard Medical School | Senior Physician, Division of Leukemia, Dana-Farber Cancer Institute | Boston, MA |
| 1:40pm | (10) Acute Myeloid Leukemia » Amir Fathi, MD – Director, Leukemia Program, Associate Professor of Medicine, Harvard Medical School, Massachusetts General Hospital | Cambridge, MA |
| 2:10pm | (11) CLL » Matthew S. Davids, MD, MMSc – Director, Clinical Research, Division of Lymphoma, Physician, Associate Professor of Medicine, Harvard Medical School | Dana-Farber Cancer Institute | Boston, MA |
| 2:40pm | (12) Stump the Faculty Q+A » Faculty for Sessions (09) – (11) |
| 2:55pm | Break – Refreshments in Exhibit Hall |
| 3:15pm | (13) Hematopoietic Stem Cell Biology » Richard Newcomb, MD – Assistant Professor of Medicine | Attending Physician | Harvard Medical School | Mass General Brigham Cancer Institute | Boston, MA |
| 3:45pm | (14) Hematopoietic Stem Cell Transplantation » Yi-Bin Chen, MD – Director, Bone Marrow Transplant Program | Massachusetts General Hospital | Boston, MA |
| 4:15pm | (15) Stump the Faculty Q+A » Faculty for Sessions (13) – (14) |
| 4:30pm | (16) Tackling the Difficult Cases » Thomas George, MBBS – PGY-5 Geriatric, Hematology/Oncology Fellow | Boston University Medical Center | Boston, MA » Alexander Bulteel, MD – Internal Medicine Resident | Beth Israel Deaconess Medical Center | Boston, MA |
| 5:00pm | Network Reception – Exhibit Hall |
| 7:00am | Check-in & Breakfast Available in Exhibit Hall |
| 7:35am | Horizon CME App Overview and CE Housekeeping |
| 7:40am | Welcome, Introductions, & CE Housekeeping |
| 7:50am | (17) Low Grade Lymphoma » Maya D. Srinivasan, MD – Assistant Professor | Boston University Chobanian & Avedisian School of Medicine | Boston, MA |
| 8:20am | Gather for Breakfast |
| 8:25am | Breakfast Buffet Non-CME/CE Presentation Sponsored by Pfizer Oncology (ELREXFIO) Advancing Care in RRMM: Clinical Evidence for a BCMA-Directed Bispecific Antibody Treatment Option » Michael Schuster, MD |
| 9:15am | Transition Break |
| 9:25am | (18) High Grade Lymphoma » Reid W. Merryman, MD – Attending Physician | Dana-Farber Cancer Institute | Boston, MA |
| 9:55am | Break – Refreshments in Exhibit Hall |
| 10:20am | (19) Myeloma & Plasma Cell Dyscrasia » Andrew Yee, MD – Clinical Director, Center for Multiple Myeloma | Assistant Professor of Medicine, Harvard Medical School | Boston, MA |
| 10:50am | (20) Stump the Faculty Q+A » Faculty for Sessions (17) – (19) |
| 11:05am | Gather Lunch |
| 11:10am | Buffet Lunch Non-CME/CE Presentation Sponsored by Pfizer Oncology (ADCETRIS): A Treatment Option for Adults with Certain R/R DLBCL After ≥2 Prior Lines of Systemic Therapy » Joshua Brody, MD |
| 11:55am | Dessert Break in Exhibit Hall |
| 12:05pm | (21) Cell Therapy » Fabio Petrocca, MD – Oncologist | Boston Medical Center | Boston, MA |
| 12:30pm | (22) CAR-T Cell Biology » Andreas Klein, MD – Interim Chief, Division of Hematology/Oncology | Tufts Medical Center | Boston, MA |
| 1:05pm | (23) Stump the Faculty Q+A » Faculty for Sessions (21) – (22) |
| 1:35pm | Adjourn |